US recommends ‘pause’ to Johnson & Johnson jab rollout over blood clot fears

US

The US Food and Drug Administration has recommended a “pause” to the rollout of the Johnson & Johnson COVID vaccine so it can investigate reports of blood clots.

Officials say they are looking into six reported cases “of a rare & severe type of blood clot in individuals after receiving the vaccine”.

“Right now, these adverse events appear to be extremely rare,” the FDA said in a statement on Twitter.

It said until the cases had been assessed for their potential significance, “we are recommending this pause”.

“This is important to ensure that the health care provider community is aware of the potential for these adverse events and can plan due to the unique treatment required with this type of blood clot,” it added.

Products You May Like

Articles You May Like

Huge blow for Sunak as Sajid Javid backs Truss in race to Number 10
Palantir shares fall more than 14% following earnings report
Sunak says Sturgeon must not be ignored after Truss calls first minister an ‘attention seeker’
Researchers Build Nanoscale Flow-Driven Rotary Motor That Can Generate Mechanical Work
Fifth man arrested over disappearance of student nurse as police renew appeal

Leave a Reply

Your email address will not be published.